| Primary |
| Glaucoma |
15.0% |
| Benign Intracranial Hypertension |
10.0% |
| Diuretic Therapy |
10.0% |
| Epilepsy |
10.0% |
| Migraine |
10.0% |
| Mountain Sickness Acute |
10.0% |
| Convulsion |
5.0% |
| Coordination Abnormal |
5.0% |
| Eye Disorder |
5.0% |
| Headache |
5.0% |
| Hyperlipidaemia |
5.0% |
| Prophylaxis |
5.0% |
| Renal Failure Chronic |
5.0% |
|
| Cholelithiasis |
9.1% |
| Vomiting |
9.1% |
| Blister |
4.5% |
| Calculus Bladder |
4.5% |
| Choroidal Effusion |
4.5% |
| Convulsion |
4.5% |
| Deafness |
4.5% |
| Diarrhoea |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Feeling Abnormal |
4.5% |
| Gun Shot Wound |
4.5% |
| Infusion Related Reaction |
4.5% |
| Nephrolithiasis |
4.5% |
| Neutrophil Count Decreased |
4.5% |
| Off Label Use |
4.5% |
| Orbital Pseudotumour |
4.5% |
| Pain |
4.5% |
| Pharmaceutical Product Complaint |
4.5% |
| Photopsia |
4.5% |
| Rectal Haemorrhage |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
24.2% |
| Drug Use For Unknown Indication |
15.8% |
| Glaucoma |
6.0% |
| Convulsion |
5.6% |
| Diabetes Mellitus |
4.9% |
| Prophylaxis |
4.2% |
| Asthma |
3.9% |
| Open Angle Glaucoma |
3.9% |
| Premedication |
3.9% |
| Surgery |
3.5% |
| Cataract Operation |
3.2% |
| Drug Detoxification |
2.8% |
| Eye Infection Toxoplasmal |
2.8% |
| Sepsis |
2.8% |
| Abdominal Pain Upper |
2.5% |
| Hypertension |
2.5% |
| Nutritional Support |
2.5% |
| Schizophrenia |
2.1% |
| Intraocular Pressure Test |
1.8% |
| Acute Myeloid Leukaemia |
1.4% |
|
| Pyrexia |
7.8% |
| Acute Generalised Exanthematous Pustulosis |
5.9% |
| Dyspnoea Exertional |
5.9% |
| Glaucoma |
5.9% |
| Metabolic Encephalopathy |
5.9% |
| Pulmonary Arterial Hypertension |
5.9% |
| Renal Failure Acute |
5.9% |
| Somnolence |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Vomiting |
5.9% |
| Diarrhoea |
3.9% |
| Drug Exposure During Pregnancy |
3.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.9% |
| Dyskinesia |
3.9% |
| Ocular Neoplasm |
3.9% |
| Renal Impairment |
3.9% |
| Thrombocytopenia |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Transaminases Increased |
3.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.8% |
| Drug Use For Unknown Indication |
17.7% |
| Prophylaxis |
8.0% |
| Glaucoma |
6.7% |
| Epilepsy |
6.0% |
| Pain |
4.4% |
| Headache |
4.3% |
| Convulsion |
3.4% |
| Juvenile Idiopathic Arthritis |
3.0% |
| Hypertension |
2.9% |
| Diabetes Mellitus |
2.7% |
| Depression |
2.5% |
| Migraine |
2.4% |
| Contraception |
2.1% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Stem Cell Transplant |
2.0% |
| Fluid Replacement |
1.8% |
| Neoplasm Malignant |
1.7% |
| Acne |
1.7% |
| Cataract Operation |
1.7% |
|
| Vomiting |
8.0% |
| Wheezing |
8.0% |
| Intraocular Pressure Increased |
7.5% |
| Vision Blurred |
6.9% |
| Pulmonary Embolism |
6.3% |
| Nausea |
5.7% |
| Pain |
5.7% |
| Visual Acuity Reduced |
5.7% |
| Glaucoma |
5.2% |
| Headache |
4.6% |
| Sepsis |
4.6% |
| Weight Decreased |
4.6% |
| Death |
4.0% |
| Intracranial Venous Sinus Thrombosis |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Weight Increased |
3.4% |
| Malaise |
2.9% |
| Pain In Extremity |
2.9% |
| Pneumonia |
2.9% |
| Respiratory Failure |
2.9% |
|
| Interacting |
| Hypertension |
24.7% |
| Cardiac Failure |
9.9% |
| Dementia |
9.9% |
| Prostatic Disorder |
9.9% |
| Blood Pressure Abnormal |
6.2% |
| Atrial Fibrillation |
4.9% |
| Cardiac Disorder |
4.9% |
| Type 2 Diabetes Mellitus |
4.9% |
| Nervous System Disorder |
3.7% |
| Urine Flow Decreased |
3.7% |
| Amnesia |
2.5% |
| Anxiety |
2.5% |
| Memory Impairment |
2.5% |
| Mineral Supplementation |
2.5% |
| Nervousness |
2.5% |
| Vitamin D Decreased |
2.5% |
| Insomnia |
1.2% |
| Vitamin D Deficiency |
1.2% |
|
| Renal Failure Acute |
50.0% |
| Balance Disorder |
25.0% |
| Drug Interaction |
12.5% |
| Vitamin D Decreased |
12.5% |
|
